{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 mutations cause autosomal recessive Parkinson disease (PD) by impairing TRAP1 phosphorylation, which is critical for protecting against oxidative-stress-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as PINK1's role in phosphorylating TRAP1 to prevent apoptosis, directly linking the gene function to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro and in vivo phosphorylation assays to demonstrate PINK1's interaction with TRAP1 and its role in cell survival under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The phosphorylation assay directly models the disease mechanism (PINK1-TRAP1 interaction) and its relevance to PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes wild-type and mutant PINK1 controls, with experiments performed in triplicate and multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type/mutant) and replicates are explicitly mentioned, satisfying Sub-step 3a requirements.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper states that PD-linked mutations (G309D, L347P, W437X) impair PINK1's ability to phosphorylate TRAP1 and promote cell survival.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses are not explicitly detailed, but the functional assay results directly correlate with pathogenicity (impaired TRAP1 phosphorylation).",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report OddsPath calculations or detailed statistical analyses for individual variants.",
          "judgment": "Yes",
          "reasoning": "Only three variants are tested, and no additional control variants are mentioned, resulting in fewer than 10 total controls.",
          "next_step_or_outcome": "Assign Max PS3_supporting"
        }
      ],
      "type": "PS3_supporting",
      "strength": "PS3_supporting",
      "conclusion": "The mutations (G309D) impair PINK1's ability to phosphorylate TRAP1, directly linking to oxidative stress-induced apoptosis, which aligns with ACMG PS3_supporting criteria."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 mutations cause PD by impairing TRAP1 phosphorylation, which is critical for protecting against oxidative-stress-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as PINK1's role in phosphorylating TRAP1 to prevent apoptosis, directly linking the gene function to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro and in vivo phosphorylation assays to demonstrate PINK1's interaction with TRAP1 and its role in cell survival under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The phosphorylation assay directly models the disease mechanism (PINK1-TRAP1 interaction) and its relevance to PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes wild-type and mutant PINK1 controls, with experiments performed in triplicate and multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type/mutant) and replicates are explicitly mentioned, satisfying Sub-step 3a requirements.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper states that PD-linked mutations (G309D, L347P, W437X) impair PINK1's ability to phosphorylate TRAP1 and promote cell survival.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses are not explicitly detailed, but the functional assay results directly correlate with pathogenicity (impaired TRAP1 phosphorylation).",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report OddsPath calculations or detailed statistical analyses for individual variants.",
          "judgment": "Yes",
          "reasoning": "Only three variants are tested, and no additional control variants are mentioned, resulting in fewer than 10 total controls.",
          "next_step_or_outcome": "Assign Max PS3_supporting"
        }
      ],
      "type": "PS3_supporting",
      "strength": "PS3_supporting",
      "conclusion": "The mutations (L347P) impair PINK1's ability to phosphorylate TRAP1, directly linking to oxidative stress-induced apoptosis, which aligns with ACMG PS3_supporting criteria."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 mutations cause PD by impairing TRAP1 phosphorylation, which is critical for protecting against oxidative-stress-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as PINK1's role in phosphorylating TRAP1 to prevent apoptosis, directly linking the gene function to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses in vitro and in vivo phosphorylation assays to demonstrate PINK1's interaction with TRAP1 and its role in cell survival under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The phosphorylation assay directly models the disease mechanism (PINK1-TRAP1 interaction) and its relevance to PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes wild-type and mutant PINK1 controls, with experiments performed in triplicate and multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type/mutant) and replicates are explicitly mentioned, satisfying Sub-step 3a requirements.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper states that PD-linked mutations (G309D, L347P, W437X) impair PINK1's ability to phosphorylate TRAP1 and promote cell survival.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses are not explicitly detailed, but the functional assay results directly correlate with pathogenicity (impaired TRAP1 phosphorylation).",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report OddsPath calculations or detailed statistical analyses for individual variants.",
          "judgment": "Yes",
          "reasoning": "Only three variants are tested, and no additional control variants are mentioned, resulting in fewer than 10 total controls.",
          "next_step_or_outcome": "Assign Max PS3_supporting"
        }
      ],
      "type": "PS3_supporting",
      "strength": "PS3_supporting",
      "conclusion": "The mutations (W437X) impair PINK1's ability to phosphorylate TRAP1, directly linking to oxidative stress-induced apoptosis, which aligns with ACMG PS3_supporting criteria."
    }
  ]
}